Клиническое исследование

A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter

NCT: NCT07788989 · NOT_YET_RECRUITING

NCT IDNCT07788989

СтатусNOT_YET_RECRUITING

Дата начала2026-10-30

Завершение2029-10-31

SponsorBiosense Webster, Inc. (INDUSTRY)

First posted2026-08-27

Last updated2026-09-15

Краткое описание

The purpose of this study is to evaluate how safe VARIPULSE™ Catheter is and how well it works in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF; irregular heartbeat where episodes start and stop on their own, usually within seven days) and symptomatic persistent atrial fibrillation (PsAF; irregular, rapid heartbeat that lasts more than 7 days and doesn't stop on its own).

Официальный источник

Открыть на ClinicalTrials.gov →

Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.